RCELAVITA Medical, Inc.
$3.92-21% 1Y
$3.92
$3.2752 weeks$13.35
Latest close: a new 52-week highOct 8, 2026what changed →
The financials
AVITA Medical, Inc. by the numbers
AVITA Medical, Inc. (RCEL) reported revenue of $22M in Q2 2026 (quarter ended Jun 30, 2026), up 18% from the same quarter a year earlier. That came with a gross margin of 82% and net loss of $7.7M. For the full year FY2025, revenue was $72M (+11% year on year) and net income −$49M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $22M | $18M | +18% |
| Gross profit | $18M | $15M | +19% |
| Operating income | −$6.9M | −$11M | n/a |
| Net income | −$7.7M | −$9.9M | n/a |
| Diluted EPS | −$0.25 | −$0.38 | n/a |
Medical Devices
Ranks #42 of 51 by RyuScore